Mythic Therapeutics, Inc.

Mythic Therapeutics is a clinical-stage biotechnology company focused on developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of various cancers. Their innovative FateControl™ technology aims to revolutionize ADC performance by enhancing their uptake in targeted tissues while minimizing payload release in healthy tissues. This approach promises to improve ADC efficacy and reduce toxicity, potentially expanding the number of patients who can benefit from these targeted therapies.

Mythic Therapeutics' lead program, MYTX-011, is a cMET-targeting ADC being investigated for the treatment of non-small cell lung cancer (NSCLC). The company has initiated a Phase 1 clinical trial to evaluate the safety and efficacy of MYTX-011 in patients with NSCLC, and they have received FDA Fast Track Designation for MYTX-011, indicating a potential for expedited review and approval. Mythic Therapeutics is committed to developing a pipeline of novel ADCs incorporating their FateControl™ technology, with the goal of re-envisioning cancer therapy and improving patient outcomes.

Mythic Therapeutics offers a flexible work environment that allows employees to collaborate effectively while also finding their own niche. This is evident through testimonials from employees and co-ops highlighting the cross-functional nature of their work and the opportunity to explore different roles. The company values a dynamic and collaborative environment that fosters learning and growth.

Mythic Therapeutics is a clinical-stage biotechnology company focused on developing next-generation antibody-drug conjugate (ADC) therapies for a wide range of cancers. They are committed to creating smarter and safer ADCs by leveraging their innovative FateControl™ technology, which aims to improve ADC uptake in targeted tissues by manipulating their fate within the cell. This groundbreaking approach has the potential to expand the use of ADCs to a broader patient population and improve treatment outcomes for those with unmet medical needs.

Mythic Therapeutics fosters a collaborative and innovative culture that values both data-driven problem solving and the willingness to take risks. Employees are encouraged to think like entrepreneurs and contribute to a dynamic work environment where teamwork is paramount. The company prioritizes "for the greater good" initiatives, emphasizing a commitment to transforming cancer therapy for the benefit of patients worldwide.

Mythic Therapeutics believes in building a diverse and inclusive workplace, fostering a culture where everyone feels valued and empowered. The company actively recruits and promotes individuals from diverse backgrounds, creating a collaborative environment where diverse perspectives are encouraged and celebrated. Mythic actively works to ensure equitable opportunities for all employees through fair hiring practices, equitable compensation and benefits, and a focus on inclusive leadership. They are committed to building a company that is a reflection of the diverse communities they serve and creating a workplace where everyone can thrive.